Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MMV533 Safety and PK in Healthy Participants
NCT04323306Phase 1Completed
- Sponsor
- Medicines for Malaria Venture
- Start
- Aug 2020
- Primary completion
- Sep 2022
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of MMV533 in malaria, sponsored by Medicines for Malaria Venture. Started Aug 2020; status: completed.
02
Drugs
MMV533
03
Conditions
malaria
Beyond the preview
Go deeper on NCT04323306.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04323306.